Listing 11.01 Category of Impairments,
Neurological
11.02 Epilepsy- convulsive epilepsy,
(grand mal or psychomotor), documented by detailed description
of a typical seizure pattern, including all associated
phenomena; occurring more frequently than once a month,
in spite of at least 3 months of prescribed treatment.
With:
--------------------------------------A. Daytime episodes
(loss of consciousness and convulsive seizures); or
--------------------------------------B. Nocturnal episodes
manifesting residuals which interfere significantly
with activity during the day.
11.03 Epilepsy- nonconvulsive epilepsy
(petit mal, psychomotor, or focal), documented by
detailed description of typical seizure pattern, including
all associated phenomena; occurring more frequently
than once weekly in spite of at least 3 months of prescribed
treatment. With alteration of awareness or loss of consciousness
and transient postictal manifestations of unconventional
behavior or significant interference with activity during
the day.
11.04 Central nervous system vascular
accident. With one of the following more than 3
months post-vascular accident:
A. Sensory or motor aphasia resulting in ineffective
speech or communication; or
B. Significant and persistent disorganization of motor
function in two extremities, resulting in sustained
disturbance of gross and dexterous movements,or gain
and station
11.05 Benign Brain turmors.
Evaluate under 11.02, 11.03, 11.04, or the criteria
of the affected body system.
11.06 Parkensonian syndrome with the following
signs: Significant rigidity, brady kinesia, or tremor
in two extremities, which, singly or in combination,
result in sustained disturbance of gross and dexterous
movements, or gait and station.
11.07 Cerebal palsy.
With:
A. IQ of 70 or less; or
B. Abnormal behavior patterns, such as destructiveness
or emotional instability; or
C. Significant interference in communication
due to speech, hearing, or visual defect; or
D. Disorganization of motor function as
described in 11.04B.
11.08 Spinal cord or nerve root lesions,
due to any cause with disorganization of motor function
as described in 11.04B.
11.09 Multiple sclerosis.
With:
A. Disorganization of motor function as
described in 11.04B; or
B. Visual or mental impairment as described under the
criteria in 2.02, 2.03, 2.04, or 12.02; or
C. Significant, reproducible fatigue of motor function
with substantial muscle weakness on repetitive activity,
demonstrated on physical examination, resulting from
neurological dysfunction in areas of the central nervous
system known to be pathologically involved by the multiple
sclerosis process.
11.10 Amyotrophic lateral sclerosis
established by clinical and laboratory findings, as
described in 11.00G
11.11 Anterior poliomyelitis. With:
A. Persistent difficulty with swallowing or breathing;
or
B. Unintelligible speech: or
C. Disorganization of motor function as described in
11.04B.
11.12 Myasthenia gravis. With:
-------A. Significant difficulty with speaking, swallowing,
or breathing while on prescribed therapy; or
-------B. Significant motor weakness of muscles of extremities
on repetitive activity against resistance while on prescribed
therapy.
11.13 Muscular dystrophy with disorganization
of motor function as described in 11.04B.
11.14 Peripheral neuropathies.
With disorganization of motor function as described
in 11.04B, in spite of prescribed treatment.
11.16 Subacute combined cord degeneration
(pernicious anemia) with disorganization of motor function
as described in 11.04B or 11.15B, not significantly
improved by prescribed treatment.
11.17 Degenerative disease not listed
elsewhere, such as Huntington's chorea, Friedreich's
ataxia, and spino-cerebellar degeneration. With:
A. Disorganization of motor function as
described in 11.04B; or
B. Chronic brain syndrome. Evaluate under 12.02.
11.18 Cerebral trauma:
Evaluate under the provisions of 11.02,
11.03, 11.04 and 12.02 as applicable.
11.19 Syringomyelia.
With:
A. Significant bulbar signs; or
B. Disorganization of motor function as described in
11.04B.
